Turn Therapeutics CEO to ring Nasdaq Closing Bell
TTRX•Nasdaq Closing Bell event scheduled for Aug. 10
- Turn Therapeutics will ring the Nasdaq Closing Bell on Aug. 10, 2026, marking progress since its October 2025 direct listing.
- CEO Bradley Burnam is scheduled to attend with the management team at Nasdaq MarketSite in Times Square, New York.
- The Closing Bell broadcast is set to begin at 3:45 p.m. ET.




